1-Hexanol, 3-mercapto-3-methyl-, (3R)-
Common Name: |
1-Hexanol, 3-mercapto-3-methyl-, (3R)- |
IUPAC Name: |
(3R)-3-methyl-3-sulfanylhexan-1-ol |
Molecular Formula: |
C7H16OS |
SMILES: |
CCCC(C)(CCO)S |
Inchi: |
1S/C7H16OS/c1-3-4-7(2,9)5-6-8/h8-9H,3-6H2,1-2H3/t7-/m1/s1 |
Inchi Key: |
PSALIMFZUGITJC-SSDOTTSWSA-N |
Cas No: |
828300-39-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
148.27 |
Mass (g/mol) |
148.092 |
Molar Refractivity |
44.89 |
Net Charge |
|
HBD |
1 |
HBA |
1 |
Rt Bonds |
4 |
Rings |
|
TPSA |
59.03 |
Hetero Atoms |
2 |
Heavy Atoms |
9 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
220.55 |
Vapor Pressure (mmHg@25.00 °C) |
0.023 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
1.857 |
iLOGP |
2.05 |
XLOGP3 |
1.69 |
WLOGP |
1.86 |
MLOGP |
1.89 |
ESOL Log S |
-1.56 |
ESOL Solubility (mg/ml) |
4.08 |
ESOL Solubility (mol/l) |
0.028 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-2.54 |
Ali Solubility (mg/ml) |
0.42 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.84 |
Silicos-IT Solubility (mg/ml) |
2.16 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.00 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.516 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.42 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |